State filing guide
CLIA waiver application and requirements in North Dakota.
Ask about my application — no payment todayNorth Dakota's personnel law distinguishes supervised exempt tests from the specific waived whole-blood glucose exemption; the application supplement remains unverified.
Sources checked 2026-11-04 · next source check due 2026-12-04
Agency clarification needed
These findings describe the linked sources. They do not establish that your facility qualifies for an exemption or that its application is ready. Facility type, ownership, personnel, locations and exact test systems can change the requirements.
We do not prepare North Dakota applications yet
Leave your email and we will write to you once, when we start taking North Dakota cases.
What the official sources say
- The HHS CLIA page links CMS-116 and personnel-licensure information. This review did not recover a current SFN 53285 test-list form; the HHS CLIA page does not list it or say it is mandatory. Obtain the current packet from HHS rather than treating an unverified test-list copy as a required initial-waiver document.
- NDCC 43-48-02 requires a current Board license to practice as a clinical laboratory scientist or technician unless an exemption applies. A facility's CLIA Certificate of Waiver does not by itself decide the operator's state personnel-license route.
- Section 43-48-03(9) exempts an individual performing exempt tests identified in Board rules only with the specified supervision. The supervisor must be Board-licensed, a physician licensed by the Board of Medicine, an advanced practice registered nurse licensed by the Board of Nursing, or another category approved by Board rule. Both must follow the methods identified by those rules; this paragraph is not a blanket exemption for every FDA-waived test.
- Section 43-48-03(13) separately exempts personnel performing whole blood glucose waived tests as categorized by the FDA. That wording does not extend the glucose exemption to a different analyte or specimen. The law also separately exempts currently licensed physicians, nurses practicing within their nursing scope, and currently licensed pharmacists.
Fees and timing
Check the current agency fee notice and fee schedule. Government fees are separate from preparation-service fees. This source summary does not promise a processing or approval date.
Check my test menuWhat still needs confirmation for your facility
- 1For each planned operator, match the exact test, specimen, professional license and supervision to a specific statutory exemption. If relying on section 43-48-03(9), confirm the current Board test list, methods and approved supervisor category rather than treating FDA-waived status as sufficient.
- 2Ask the HHS Health Facilities Unit for the current initial-waiver packet and whether a current test-list supplement is needed. This review has not recovered SFN 53285 or confirmed its edition, mandatory status or submission channel.
Frequently asked questions
What filing route does the cited North Dakota guidance describe?
North Dakota's personnel law distinguishes supervised exempt tests from the specific waived whole-blood glucose exemption; the application supplement remains unverified.
Which requirements are named in the cited North Dakota materials?
The HHS CLIA page links CMS-116 and personnel-licensure information. This review did not recover a current SFN 53285 test-list form; the HHS CLIA page does not list it or say it is mandatory. Obtain the current packet from HHS rather than treating an unverified test-list copy as a required initial-waiver document. NDCC 43-48-02 requires a current Board license to practice as a clinical laboratory scientist or technician unless an exemption applies. A facility's CLIA Certificate of Waiver does not by itself decide the operator's state personnel-license route. Section 43-48-03(9) exempts an individual performing exempt tests identified in Board rules only with the specified supervision. The supervisor must be Board-licensed, a physician licensed by the Board of Medicine, an advanced practice registered nurse licensed by the Board of Nursing, or another category approved by Board rule. Both must follow the methods identified by those rules; this paragraph is not a blanket exemption for every FDA-waived test. Section 43-48-03(13) separately exempts personnel performing whole blood glucose waived tests as categorized by the FDA. That wording does not extend the glucose exemption to a different analyte or specimen. The law also separately exempts currently licensed physicians, nurses practicing within their nursing scope, and currently licensed pharmacists.
What do the sources establish about fees and timing in North Dakota?
Check the current agency fee notice and fee schedule. Government fees are separate from preparation-service fees. This source summary does not promise a processing or approval date.
Does this page confirm CLIA approval or legal compliance in North Dakota?
No. This is an educational prep checklist. It does not confirm approval, legal compliance, or waived status for any specific device. Verify every requirement with CMS, the FDA, and your state agency before testing.
Other jurisdictions
Each jurisdiction publishes its own terminology, forms, channel, signatures, and fees.
All 52jurisdictions →Need help with your North Dakota CLIA route?
Tell us where your clinic operates and what you need to prepare or change. You can ask before you know your exact test system. We review the next facts needed before proposing any paid scope.
Request a scope inquiry — no payment today
Business inquiries only. Do not send patient information, test results, dates of birth, government identifiers, credential numbers, or documents.
From test research to your North Dakota application
An analyte label does not confirm a device. The exact test system and the clinic’s state route need separate review before a filing scope or price can be confirmed.